Stryker announced successful completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.
The Infinity Total Ankle comprises a titanium alloy tibial tray, cobalt chromium talar dome and polyethylene insert and features a low-profile tibial implant design. The Adaptis 3D-printed total ankle implants incorporate porous metal components strategically designed to act as a scaffold, facilitating bony ingrowth. The Everlast highly cross-linked polyethylene inserts, blended with vitamin E, have been demonstrated to improve wear resistance. The interchangeability of the two talar options adds versatility to the system, designed for catering to diverse patient needs.
The system is optimized for efficiency through Prophecy Surgical Planning, which includes patient-specific instruments.
“Infinity with Adaptis builds on the legacy of the original Infinity Total Ankle, with a decade of clinical use. Recent publication data showed a 98.8% survivorship at two years of the original Infinity implant, demonstrating its safety and efficacy as a low-profile prosthesis for surgeons treating end-stage ankle arthritis,” said Markus Ochs, Vice President and General Manager of Stryker’s European Trauma & Extremities business. “These initial procedures highlight Stryker’s dedication to innovation and commitment through research, enhancing our collaboration with surgeons.”
Stryker announced successful completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.
The Infinity Total Ankle comprises a titanium alloy tibial tray, cobalt chromium talar dome and polyethylene insert and features a low-profile tibial implant design. The Adaptis 3D-printed total...
Stryker announced successful completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology.
The Infinity Total Ankle comprises a titanium alloy tibial tray, cobalt chromium talar dome and polyethylene insert and features a low-profile tibial implant design. The Adaptis 3D-printed total ankle implants incorporate porous metal components strategically designed to act as a scaffold, facilitating bony ingrowth. The Everlast highly cross-linked polyethylene inserts, blended with vitamin E, have been demonstrated to improve wear resistance. The interchangeability of the two talar options adds versatility to the system, designed for catering to diverse patient needs.
The system is optimized for efficiency through Prophecy Surgical Planning, which includes patient-specific instruments.
“Infinity with Adaptis builds on the legacy of the original Infinity Total Ankle, with a decade of clinical use. Recent publication data showed a 98.8% survivorship at two years of the original Infinity implant, demonstrating its safety and efficacy as a low-profile prosthesis for surgeons treating end-stage ankle arthritis,” said Markus Ochs, Vice President and General Manager of Stryker’s European Trauma & Extremities business. “These initial procedures highlight Stryker’s dedication to innovation and commitment through research, enhancing our collaboration with surgeons.”
Copy to clipboard 
